IL-37通过减轻上皮层-介质细胞过渡和促进M2巨细胞极化来改善慢性子宫内膜炎
Zihan Wang1, Jiaxi Tan1, Rui Zhang1
1School of Medical Technology and Translational Medicine, Hunan Normal University, Tongzipo Road, Changsha 410013, China.
Current issues in molecular biology
|February 27, 2026
概括
干白素-37 (IL-37) 通过减少炎症和组织损伤来缓解慢性子宫内膜炎 (CE). 它抑制了表皮-介质细胞过渡 (EMT) 并促进M2巨细胞两极分化,为CE提供了潜在的治疗益处.
科学领域:
- 生殖免疫学 生殖免疫学
- 细胞和分子生物学是细胞和分子生物学.
背景情况:
- 慢性子宫内膜炎 (CE) 是一种炎症性子宫疾病,治疗目标不明.
- 介素-37 (IL-37) 是一种抗炎性细胞因子,在CE病变发生过程中具有未明确的作用.
- 表皮-介质细胞过渡 (EMT) 和巨细胞两极分化都与CE有关.
研究的目的:
- 在CE的老鼠模型中研究IL-37的治疗机制.
- 为了探索IL-37对EMT和CE的巨细胞极化的影响.
- 为了阐明参与IL-37的作用的分子途径.
主要方法:
- 通过使用脂聚糖 (LPS) 诱导CE的老鼠模型,并用IL-37.7治疗.
- 采用了组织学,免疫光,透孔,qPCR,西部斑块和流动细胞计分析.
- 评估了STAT6和Smad3通路的激活.
主要成果:
- 治疗IL-37可以减少子宫炎症,组织损伤和纤维化.
- 通过对E-cadherin进行上调和对维门丁进行下调,IL-37抑制了EMT.
- IL-37抑制了M1巨细胞的两极分化,并促进了M2两极分化.
- IL-37协同激活了STAT6和Smad3通路,增加了ARG1的表达.
结论:
- 通过减轻炎症和组织损伤,IL-37证明了CE的治疗潜力.
- 通过抑制EMT和促进M2巨细胞极化,IL-37可以改善CE.
- STAT6和Smad3通路的协调激活介导了IL-37在CE中的保护作用.
相关概念视频
Inflammatory Bowel Disease II: Ulcerative Colitis
34
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
Inflammatory Bowel Disease III: Crohn's Disease
35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35


